Are DLI cells the same as infused at the time of Allo-HSCT or only a subset of those cells? Format your response so...

TL;DR

DLI (donor lymphocyte infusion) cells are not the same cells infused during your original transplant—they're freshly collected from your donor and may have different properties, which is why they can work differently for your mixed chimerism.

---

KEY POINTS

• DLI uses fresh donor cells, not stored cells from your original transplant
• The donor's immune system may have changed since your transplant (months or years ago)
• DLI cells are selected and processed differently than transplant cells, often enriched for T cells
• Your mixed chimerism (5% donor cells detected) is exactly the type of situation where DLI might help boost donor cell recovery
• The composition and potency of DLI can be customized based on your current needs

---

NEXT STEP

Ask your transplant team: "Are you considering DLI for my mixed chimerism, and if so, would the cells be T-cell enriched or unmanipulated donor cells?"

---

FULL ANSWER

Understanding DLI vs. Original Transplant Cells

When you received your allogeneic hematopoietic stem cell transplant (allo-HSCT), your donor provided a carefully selected and processed product containing stem cells, T cells, and other immune cells—all collected at that specific moment in time.

DLI (donor lymphocyte infusion) is fundamentally different. It's a fresh collection of cells from your same donor, typically obtained months or even years after your original transplant. Here's why this distinction matters:

Key Differences Between Transplant Cells and DLI Cells

1. Timing & Donor Biology

• Your original transplant cells were collected on Day 0 of your transplant
• DLI cells are collected later—sometimes 6 months, 1 year, or longer after transplant
• Your donor's immune system may have evolved in that time (new T cell responses, different antibody profiles)
• The donor may have been exposed to new infections or antigens since the original collection

2. Cell Composition & Selection

• Original transplant: Contains a broad mix of stem cells (CD34+), T cells (CD3+), B cells (CD19+), and myeloid cells (CD15+)
• DLI: Usually enriched for T lymphocytes (CD3+ cells), which are the primary cells driving the graft-versus-leukemia (GVL) effect
• DLI can be further manipulated—some protocols use unmanipulated donor lymphocytes, while others select specific T cell subsets

3. Processing & Cryopreservation

• Original transplant cells: Fresh collection, minimal processing, infused immediately
• DLI cells: May be fresh or thawed from cryopreserved (frozen) donor cells, depending on your center's protocol

Why This Matters for Your Mixed Chimerism

Your recent testing shows CD34 0% donor cells—meaning your donor's stem cells have largely been replaced by your own (recipient) cells. This is mixed chimerism, and it's a situation where DLI can be particularly useful because:

1. DLI provides fresh donor T cells that can recognize and attack residual recipient hematopoietic cells
2. The graft-versus-tumor (GVT) effect from DLI T cells may help restore full donor chimerism
3. DLI doesn't require conditioning (chemotherapy/radiation), which is why it's often used as a lower-toxicity intervention for mixed chimerism

Clinical Context: DLI for Mixed Chimerism

According to NCCN Guidelines for Hematopoietic Cell Transplantation, DLI is considered a standard intervention for patients with mixed chimerism who have:

• Declining donor chimerism
• Risk of graft failure or relapse
• Adequate performance status to tolerate potential GVHD

Your current symptoms (high blast cells, high eosinophils, low lymphocytes) suggest your hematopoietic recovery may be incomplete, which makes DLI evaluation particularly relevant.

Questions to Ask Your Transplant Team

1. "Given my mixed chimerism and current cell counts, is DLI being considered?"
2. "Would the DLI cells be T-cell enriched, and if so, what CD3+ dose are you targeting?"
3. "How will you monitor my chimerism after DLI to see if it's working?"
4. "What's the risk of GVHD with DLI, given that I'm already managing cGVHD with Jakafi?"
5. "If DLI is planned, will the cells be fresh or thawed from cryopreserved donor cells?"

Important Boundary

This information is for educational purposes only. Your transplant team will determine whether DLI is appropriate for YOUR specific case, based on your complete clinical picture, donor availability, and risk-benefit analysis. The decision to proceed with DLI—and the specific protocol used—requires personalized medical judgment.

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.